A comparison of neuropeptide expression in skin with allergic contact dermatitis in human and mouse

International Journal of Dermatology

Volumn 51, Issue 8, 2012, Pages 939-946

  Lim, Yun Young ^a   Kim, Hyeong Mi ^a   Lee, Hye In ^a   Mun, Seog Kyun ^b   Kim, Chan Woong ^b   Kim, Myeung Nam ^a   Kim, Beom Joon ^a  

^a Chung Ang University   (South Korea)

^b Chung Ang University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; EOSIN; HEMATOXYLIN; SUBSTANCE P;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN; SKIN ALLERGY;

ADULT; ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; CYTOKINES; DERMATITIS, ALLERGIC CONTACT; FEMALE; HUMANS; MAST CELLS; MICE; PEPTIDYL-DIPEPTIDASE A; SKIN; SUBSTANCE P; YOUNG ADULT;

EID: 84864003911     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2011.05197.x     Document Type: Article

References (25)

1. Gutwald J, Goebeler M, Sorg C. Neuropeptides enhance irritant and allergic contact dermatitis. J Invest Dermatol 1991; 96: 695-698.
2. Ansel JC, Armstrong CA, Song I, et al. Interactions of the skin and nervous system. J Invest Dermatol Symp Proc 1997; 2: 23-26.
3. Asahina A, Hosoi J, Beissert S, et al. Inhibition of the induction of delayed-type and contact hypersensitivity by calcitonin gene-related peptide. J Immunol 1995; 154: 3056-3061.
4. Luger TA. Neuromediators - a crucial component of the skin immune system. J Dermatol Sci 2002; 30: 87-93.
5. Scholzen TE, Luger TA. Neutral endopeptidase and angiotensin-converting enzyme - key enzymes terminating the action of neuroendocrine mediators. Exp Dermatol 2004; 13: 22-26.
6. Rossi R, Johansson O. Cutaneous innervation and the role of neuronal peptides in cutaneous inflammation: a mini-review. Eur J Dermatol 1998; 8: 299-306.
7. Wallengren J. Dual-effect of CGRP-antagonist on allergic contact dermatitis in human skin. Contact Dermatitis 2000; 43: 137-143.
8. Luger TA, Lotti T. Neuropeptides: role in inflammatory skin disease. J Eur Acad Dermatol Venereol 1998; 10: 207-211.
9. Church MK, Lowman MA, Rees PH, et al. Mast cells, neuropeptides and inflammation. Agents Actions 1989; 27: 8-16.
10. Liu J-Y, Hu J-H, Zhu Q-G, et al. Substance P receptor expression in human skin keratinocytes and fibroblasts. Br J Dermatol 2006; 155: 657-662.
11. Park YM, Kim CW. The effects of substance P and vasoactive intestinal peptide on interleukin-6 synthesis in cultured human keratinocytes. J Dermatol Sci 1999; 22: 17-23.
12. Yu B, Koga T, Urabe K, et al. Differential regulation of thymus- and activation-regulated chemokine induced by IL-4, IL-3, TNF-α and IFN-γ in human keratinocyte and fibroblast. J Dermatol Sci 2002; 30: 29-36.
13. Okabe T, Hide M, Koro O, et al. Substance P induces tumor necrosis factor-α release from human skin via mitrogen-activated protein kinase. Eur J Phamacol 2000; 398: 309-315.
14. Laouini D, Alenius H, Bryce P, et al. IL-10 is critical for Th2 responses in a murine model of allergic dermatitis. J Clin Invest 2003; 112: 1058-1066.
15. Ling P, Gately MK, Gubler U, et al. Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J Immunol 1995; 154: 116-127.
16. Sebastiani S, Albanesi C, De Pità O, et al. The role of chemokines in allergic contact dermatitis. Arch Dermatol Res 2002; 293: 552-559.
17. Scholzen T, Armstrong CA, Bunnett NW, et al. Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune systems. Exp Dermatol 1998; 7: 81-96.
18. Wallengren J, Ekman R, Sundler F. Occurrence and distribution of neuropeptides in the human skin. An immunocytochemical study on normal skin and blister fluid from inflamed skin. Acta Derm Venereol 1987; 67: 185-192.
19. Fox FE, Kubin M, Cassin M, et al. Calcitonin gene-related peptide inhibits proliferation and antigen presentation by human peripheral blood mononuclear cells: effects and B7, interleukin 10, and interleukin 12. J Invest Dermatol 1997; 108: 43-48.
20. Asahina A, Moro O, Hosoi J, et al. Specific induction of cAMP in Langerhans cells by calcitonin gene-related peptides: relevance to functional effects. Proc Natl Acad Sci USA 1995; 92: 8323-8327.
21. Torii H, Hosoi J, Beissert S, et al. Regulation of cytokine expression in macrophages and the Langerhans cell-like line XS52 by calcitonin gene-related peptide. J Leukoc Biol 1997; 61: 216-223.
22. Goebeler M, Henseleit U, Roth J, Sorg C. Substance P and calcitonin gene-related peptide modulate leukocyte infiltration to mouse skin during allergic contact dermatitis. Arch Dermatol Res 1994; 286: 341-346.
23. Brain SD, Williams TJ. Substance P regulates the vasodilator activity of calcitonin gene-related peptide. Nature 1988; 335: 73-75.
24. Wallengren J, Wang ZY. Interactions between tachykinins and CGRP in human skin. Acta Derm Venereol 1993; 73: 259-261.
25. Lotti T, Hautmann G, Panconesi E. Neuropeptides in skin. J Am Acad Dermatol 1995; 33: 482-496.